|
|
|
|
|
|
|
|
|
The Wright Reports site is no longer hosted or operated by Manta. Please review
the following:
1. You have been redirected to CorporateInformation.com where you can view
Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to
www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on
to the member site:
http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact
help@corporateinformation.com, Contact phone nr to be provided later)
|
|
|
|
|
|
 |
|
|
|
|
|
|
 |
|
Starpharma Holdings Limited
Company Snapshot
|
|
Business Description:
Starpharma Holdings Limited operates in the Noncommercial research organizations sector. Starpharma Holdings Limited (SPL) is a biotechnology company engaged in the development of dendrimer products for pharmaceutical, life science and other applications. Activities within the Company are directed towards the development of nano-scale materials, with a particular focus on the development of its topical vaginal microbicide VivaGel for the treatment and prevention of bacterial vaginosis (BV); prevention of transmission of sexually transmitted infection (STIs), including human immunodeficiency virus (HIV) and genital herpes, and the application of dendrimers to drug delivery and other life science applications. Through partners, it is exploring dendrimer opportunities in materials science with applications in areas such as cosmetics, agrochemicals, coatings, adhesives and water. As of June 30, 2011, it had three Australian subsidiaries, such as Starpharma Pty Ltd, Angiostar Pty Limited and Viralstar Pty Limited, and one United States-based subsidiary, DNT, Inc.
|
|
| |
|
| |
|
| |
|
|
|
|
|
|
|
|
| |
| |
Stock Data: |
Recent Stock Performance: |
|
| |
Current Price (2/3/2012):
1.35
(Figures in
Australian Dollars) |
|
1 Week |
12.0% |
|
13 Weeks |
16.9% |
|
|
|
|
|
|
|
|
|
4 Weeks |
29.2% |
|
52 Weeks |
38.5% |
|
|
|
| |
| |
Starpharma Holdings Limited
Key Data: |
|
|
|
| |
Ticker: |
SPL |
Country: |
AUSTRALIA |
| |
|
| |
Exchanges: |
FRA OTC |
Major Industry: |
Retailers |
| |
|
| |
|
|
Sub Industry: |
Drug Store Chains |
| |
|
| |
2000
Sales |
(Year Ending Jan 2001). |
Employees: |
32 |
| |
|
| |
Currency: |
Australian Dollars |
Market Cap: |
334,453,830 |
| |
|
| |
Fiscal Yr Ends: |
June |
Shares Outstanding: |
247,743,578 |
| |
|
| |
Share Type: |
Ordinary |
Closely Held Shares: |
66,146,224 |
|
| |
|
| |
| |
|
|
|
CorporateInformation® website and selected data Copyright © 2000 -
by The Winthrop Corporation. All Rights Reserved. Except for quotations by established
news media, no pages on this site may be reproduced, stored in a retrieval system,
or transmitted for commercial purposes, in any form or by any means, electronic,
mechanical, photocopying, recording, or otherwise without prior written permission.
Information is believed reliable, but accuracy, completeness and opinions are not
guaranteed.
|
|
|
|
|